Serum mesothelin levels were significantly higher in the patients with mesothelioma than in those with metastatic cancers to pleura, benign asbestos pleurisy, benign pleural diseases or pleural diseases other than mesothelioma (Fig. 1a, Table 2). The gene discussed is MSLN; the disease is metastatic malignant neoplasm.